Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777734
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-04-29
First Post:
2021-02-26
Brief Title:
Efgartigimod Expanded Access for Generalized Myasthenia Gravis
Sponsor:
argenx
Organization:
argenx
Organization Data
Organization:
argenx
Class:
INDUSTRY
Study ID:
ARGX-113-EAP-2101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
argenx
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None